UK's Mobile Medical Apps Guidance Parallels FDA's

Law360, New York (March 21, 2014, 4:44 PM EDT) -- U.K. regulators on Wednesday published guidance explaining how they’ll police the booming field of mobile medical apps, adopting an approach that in many ways appeared to dovetail with the U.S. Food and Drug Administration's policies.

The guidance provided numerous examples of apps and other stand-alone software that will be viewed as medical devices and therefore have to go through an approval process, or “conformity assessment,” that varies depending a product’s level of risk.

Bradley Merrill Thompson, a medical apps expert at Epstein Becker & Green PC,...
To view the full article, register now.